A Gyselen

472 total citations
28 papers, 318 citations indexed

About

A Gyselen is a scholar working on Pulmonary and Respiratory Medicine, Infectious Diseases and Surgery. According to data from OpenAlex, A Gyselen has authored 28 papers receiving a total of 318 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Pulmonary and Respiratory Medicine, 10 papers in Infectious Diseases and 8 papers in Surgery. Recurrent topics in A Gyselen's work include Tuberculosis Research and Epidemiology (9 papers), Diagnosis and treatment of tuberculosis (4 papers) and Chronic Obstructive Pulmonary Disease (COPD) Research (4 papers). A Gyselen is often cited by papers focused on Tuberculosis Research and Epidemiology (9 papers), Diagnosis and treatment of tuberculosis (4 papers) and Chronic Obstructive Pulmonary Disease (COPD) Research (4 papers). A Gyselen collaborates with scholars based in Belgium, Netherlands and Austria. A Gyselen's co-authors include K. P. Van de Woestijne, D. Lahaye, Eric Verbeken, Joseph M. Lauweryns, Maurits Demedts, L Eyckmans, J. Wildiers, Georges Deneffe, L. Verbist and J Prignot and has published in prestigious journals such as CHEST Journal, Respiration and Acta Clinica Belgica.

In The Last Decade

A Gyselen

22 papers receiving 269 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
A Gyselen Belgium 7 196 71 65 34 28 28 318
W D Riding United Kingdom 8 169 0.9× 73 1.0× 98 1.5× 24 0.7× 31 1.1× 16 313
I. W. Fawcett United Kingdom 12 83 0.4× 66 0.9× 167 2.6× 20 0.6× 64 2.3× 17 370
Walter H. Thiede United States 7 179 0.9× 39 0.5× 83 1.3× 36 1.1× 116 4.1× 11 373
Edward F. Banaszak United States 6 166 0.8× 33 0.5× 96 1.5× 28 0.8× 119 4.3× 12 350
Carl B. Sherter United States 9 261 1.3× 73 1.0× 18 0.3× 46 1.4× 23 0.8× 14 373
C. Thomas Boylen United States 15 178 0.9× 29 0.4× 79 1.2× 41 1.2× 76 2.7× 20 518
Leonardo Reyes Spain 6 283 1.4× 94 1.3× 133 2.0× 27 0.8× 38 1.4× 10 761
M. M. Kerr United Kingdom 11 109 0.6× 12 0.2× 29 0.4× 58 1.7× 8 0.3× 25 342
Jatinder Bhatia United States 11 184 0.9× 37 0.5× 25 0.4× 110 3.2× 12 0.4× 25 418
Aziz Gümüş Türkiye 11 122 0.6× 41 0.6× 24 0.4× 31 0.9× 9 0.3× 44 289

Countries citing papers authored by A Gyselen

Since Specialization
Citations

This map shows the geographic impact of A Gyselen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by A Gyselen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites A Gyselen more than expected).

Fields of papers citing papers by A Gyselen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by A Gyselen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by A Gyselen. The network helps show where A Gyselen may publish in the future.

Co-authorship network of co-authors of A Gyselen

This figure shows the co-authorship network connecting the top 25 collaborators of A Gyselen. A scholar is included among the top collaborators of A Gyselen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with A Gyselen. A Gyselen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Woestijne, K. P. Van de, et al.. (2015). Weight Changes in the Terminal Stages of Chronic Obstructive Pulmonary Disease1, 2. American Review of Respiratory Disease. 1 indexed citations
2.
Gyselen, A, et al.. (2002). [Possible primary lymphosarcoma of the lung; presentation of a case].. Acta Clinica Belgica. 12(2). 195–204.
3.
Verhaegen, H., et al.. (1998). [The diagnosis of sarcoidosis. Review of 87 histologically verified cases].. PubMed. 53. 221–31.
4.
Brande, P. Van den, A Gyselen, & M. Demedts. (1988). Roentgenographic Manifestations Of Pulmonary Tuberculosis In The Adult: Frequency Of Atypical Findings. Acta Clinica Belgica. 43(1). 58–61. 2 indexed citations
5.
Moor, Pieter De, M. Demedts, Dirk Faict, & A Gyselen. (1984). Transient High Transcortin Levels in Patients With Sputum-Positive Pulmonary Tuberculosis. Acta Clinica Belgica. 39(6). 358–362. 1 indexed citations
6.
Demedts, Maurits, et al.. (1984). Cobalt lung in diamond polishers.. PubMed. 130(1). 130–5. 76 indexed citations
7.
Fevery, Johan, et al.. (1980). [Fulminating hepatitis caused by administration of isoniazid and rifampicin in a patient under chronic treatment with barbiturates].. PubMed. 124(25). 1008–12. 1 indexed citations
8.
Bouillon, Roger, et al.. (1979). Familial pulmonary fibrosis with hypocalciuric hypercalcemia. CHEST Journal. 76. 350–350. 1 indexed citations
9.
Dubois, Pierre, A Gyselen, & J Prignot. (1977). Rifampim-combined chemotherapy in coal worker's pneumoconio-tuberculosis.. PubMed. 115(2). 221–8. 1 indexed citations
10.
Gyselen, A & L. Verbist. (1972). [Has the intermittent therapy of pulmonary tuberculosis a future in industrialised countries?].. PubMed. 26(5). 269–82.
11.
Gyselen, A, et al.. (1972). Five years of clinical experience with rifampicin.. PubMed. 62(4). 289–307. 2 indexed citations
12.
Gyselen, A, et al.. (1969). Clinical results in first treatment and retreatment of advanced pulmonary tuberculosis with rifampicin. Tubercle. 50(3). 328–329. 7 indexed citations
13.
Eyckmans, L, et al.. (1968). Pigeon Breeder's Lung. Diseases of the Chest. 53(3). 358–364. 41 indexed citations
14.
Gyselen, A, et al.. (1968). Evolution of Tuberculin Sensitivity with Advancing Age. Gerontologia Clinica. 10(6). 369–374. 6 indexed citations
15.
Gyselen, A. (1968). [Ethambutol, tuberculostatic of the future?].. PubMed. 58(2). 111–8.
16.
Woestijne, K. P. Van de, et al.. (1967). Weight changes in the terminal stages of chronic obstructive pulmonary disease. Relation to respiratory function and prognosis.. PubMed. 95(4). 556–66. 105 indexed citations
17.
Verbist, L., et al.. (1966). Tolerance to ethionamid and PAS in original treatment of tuberculous patients.. PubMed. 47(4). 225–35. 5 indexed citations
18.
Gyselen, A, et al.. (1965). Capreomycin in the re-treatment of patients with pulmonary tuberculosis. Tubercle. 46(3). 243–249. 4 indexed citations
19.
Gyselen, A, et al.. (1964). Osteoplastic Tracheopathy. Diseases of the Chest. 45(3). 332–335. 3 indexed citations
20.
Gyselen, A, et al.. (1957). Lymphosarcome Primitif Du Poumon ?. Acta Clinica Belgica. 12(2). 195–204. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by W D Riding Breakdown of academic impact, for papers by I. W. Fawcett Breakdown of academic impact, for papers by Walter H. Thiede Breakdown of academic impact, for papers by Edward F. Banaszak Breakdown of academic impact, for papers by Carl B. Sherter Breakdown of academic impact, for papers by C. Thomas Boylen Breakdown of academic impact, for papers by Leonardo Reyes Breakdown of academic impact, for papers by M. M. Kerr Breakdown of academic impact, for papers by Jatinder Bhatia Breakdown of academic impact, for papers by Aziz Gümüş
Rankless by CCL
2026